Rachel Lenington
2022
In 2022, Rachel Lenington earned a total compensation of $2M as Chief Operating Officer at Athira Pharma, a 21% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $147,920 |
|---|---|
| Option Awards | $1,450,891 |
| Salary | $430,000 |
| Other | $85 |
| Total | $2,028,896 |
Lenington received $1.5M in option awards, accounting for 72% of the total pay in 2022.
Lenington also received $147.9K in non-equity incentive plan, $430K in salary and $85 in other compensation.
Rankings
In 2022, Rachel Lenington's compensation ranked 1,730th out of 5,760 executives tracked by ExecPay. In other words, Lenington earned more than 70.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,730 out of 5,760 | 70th |
Division Manufacturing | 909 out of 3,136 | 71st |
Major group Chemicals And Allied Products | 369 out of 1,422 | 74th |
Industry group Drugs | 337 out of 1,323 | 75th |
Industry Biological Products, Except Diagnostic Substances | 83 out of 291 | 72nd |
Source: SEC filing on April 5, 2023.
Lenington's colleagues
We found two more compensation records of executives who worked with Rachel Lenington at Athira Pharma in 2022.